The Defense Logistics Agency - Troop Support is soliciting proposals for the supply of Intranasal Influenza Vaccine for the 2013-2014 and 2014-2015 flu seasons. A one-year indefinite quantity contract with an option for an additional annual period is solicited. Approximately 1.4 million doses for each annual period are included in this requirement. (Quantities may increase or decrease pending receipt of actual Service requirements.)

The vaccine shall be shall be a live, attenuated, intranasal, quadrivalent vaccine, licensed by the FDA, intended for active immunization for the prevention of influenza. The vaccine shall meet the minimum formula for the influenza vaccine as determined by the FDA's Vaccines and Related Biological Products Advisory Committee. The vaccine shall be a pre-measured 0.2 ML dose, each dose shall be pre-filled in a commercially available nasal syringe unit suitable for nasal administration in healthy individuals aged 2 years through 49 years.

Other specification data included in the solicitation. Successful contractor must have FDA approval. National Stock Numbers shall be established at time of award.

An indefinite quantity type contract is proposed. The quantities indicated are annual estimates only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 1.8 million doses.

The vaccine shall be delivered directly to military treatment facilities and DoD activities worldwide. The contractor shall be capable of delivering a minimum 50% of the estimated annual quantity by August 31; 30% by September 30; and the remaining 20% by October 31 in each year of the contract.

 

Bid Protests Not Available